JENNIFER BROWN: Open Payments
NPI 1538555602 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 14 payments from 5 companies in 2025. Trend: 2023 $964 · 2024 $1,238 · 2025 $497
Food & beverage: $297Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $200 |
| GlaxoSmithKline, LLC. | 10 | $149 |
| AstraZeneca Pharmaceuticals LP | 1 | $113 |
| CORDIS US CORP. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $16 |
Products named: Adempas, TRELEGY ELLIPTA, BREZTRI, MYNX CONTROL VENOUS, INSPIRE.
Industry payments across NV — which companies pay providers there.
